» Home

» People

• Norman J. Kachuck, M.D.
• Leslie P. Weiner, M.D.
• Margaret Burnett, M.D.
• Daniel Bandari, M.D.
• Regina Berkovich, MD, Ph.D
• Lanelle Cua
• Patricia Gutierrez
• M. Linda H. Ignacio
• José Aparicio
• Patricia Rourke

» Location

» What We Do

• Diagnosis and Treatment
• Management Strategies
• Research Towards the cure
• Direct Access To Clinical Trials
• Center for Innovative Research
• Physician Education And Consultation

» Clinical Trials

• Interferon Tau Oral Therapy for Relapsing-Remitting MS
• Lipitor Trial For Patients with Presumptive MS
• Anti-IL 12 Monoclonal Antibody Rejection
• DNA Vaccine Phase I Trial
• Rituximab (Rituxan ®) Treatment in Peimary Progressive MS
• Avonex Combined Trial (ACT) for Patients on IFN-BETA-
• Pregnancy and Immune Function in MS
• Open Label Follow-Up Trial of Glatiramer Acetate (COPAXONE) in Relapsing Remitting MS
• Combined AVONEX and NOVANTRONE Therapy Iin MS (CANTIMUS)
• Sentinel (C-1802) Study
• 1808 Extension Study

» Questions

» Basic Science

» Useful Links

• National MS Society
• NMSS SoCal Chapter
• Erase MS
• MS.com
• Act for MS
• USC Department of Neurology
  

USC Department of Neurology

USC MS Comprehensive Care Center
Healthcare Consultation Center II
1520 San Pablo St., Suite 3000
Los Angeles, CA 90033

Administrative Office:
323-442-6870
Fax: 323-442-5773
Email: mscare@usc.edu

For directions, click here

Patient Care
For Appointments, call
323-442-5710
For Clinical Trials, click here

Physicians and Other Professionals
Call: 323-442-6870
FAX: 323-442-5773
Email: mscare@usc.edu